Kolexia
Lorgis Veronique
Oncologie médicale
Clinique Mutualiste Benigne Joly
Talant, France
103 Activités
223 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Tumeurs du cerveau Récidive tumorale locale Tumeurs colorectales Tumeurs du sein triple-négatives Carcinomes Glioblastome Tumeur du sein de l'homme

Industries

Novartis
24 collaboration(s)
Dernière en 2023
B3TSI
20 collaboration(s)
Dernière en 2022
Daiichi Sankyo
17 collaboration(s)
Dernière en 2023
Lilly
17 collaboration(s)
Dernière en 2023

Dernières activités

TARGETMONITO: Dosing of Various Multi Kinases Inhibitors Plasma Concentrations for Patients Treated for Their Advanced Digestive Cancer, With the Aim to Determine the Best Optimal Dose for Each Treatment, in the Future
Essai Clinique (Unicancer)   29 février 2024
2379P AVENANCE: Subgroup analysis of patients (pts) with advanced urothelial carcinoma (aUC) with histological variants from a real-world (RW) study of avelumab first-line maintenance (1LM)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
GETUG-StORM-01: A Randomized Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
ESME-MBC: Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Metastatic Breast Cancer Across the French Comprehensive Cancer Centers From 2008
Essai Clinique (Seagen)   16 mars 2023
COMET: Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab (AVASTIN ®) in Combination With Weekly Paclitaxel Chemotherapy in First Line Treatment Patients With Metastatic Breast Cancer
Essai Clinique (Unicancer)   25 janvier 2023
1757P Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC)
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Aflibercept-LV5FU2 as first-line treatment of non-resectable metastatic colorectal cancers: Results of the FOLFA randomized phase II trial.
2022 ASCO Annual Meeting I   02 juin 2022
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
Neuro-oncology   09 mai 2022
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.
Cancer chemotherapy and pharmacology   08 janvier 2022
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database.
Breast (Edinburgh, Scotland)   01 octobre 2021